
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Elpro International has started a voluntary delisting process from BSE, outlining the promoter-led acquisition structure, regulatory conditions, due diligence steps, and a pricing mechanism yet to be disclosed.
CFF Fluid Control approved audited FY26 results, reporting revenue of ₹208.74 crore and net profit of ₹39.20 crore, alongside a ₹0.75 final dividend recommendation.
Sun Pharma is lining up euro bonds, bondholder swaps, and offshore loans to finance its $11.75 billion all-cash acquisition of US-listed Organon.
SRF reported higher Q4 and full-year profit, revised its Odisha refrigerants project investment to Rs 2,300 crore, and reiterated FY26 capex guidance of Rs 2,200-2,300 crore.
Motilal Oswal data shows DIIs raised Nifty 500 ownership to a record 20.9% in March 2026, while FIIs fell to 17.1% amid net outflows.
India has notified rules allowing 100% foreign investment in insurers via the automatic route, with IRDAI verification, pricing guidelines under FEMA, and a 20% cap for LIC.
Pfizer’s preliminary 2026 annual meeting votes backed director elections, KPMG’s auditor appointment, an amended stock plan, and executive pay, while rejecting an independent chair proposal.
NCLAT set aside the NCLT’s December 2025 order admitting CIRP against Embassy Developments, citing IBC Section 10A, after a Canara Bank plea over INR 200 crore.
Croissance Ltd approved unaudited Q3 FY26 results for the December 2025 quarter, reporting nil revenue from operations and ₹20.27 crore in other income.
United Breweries will meet on May 5, 2026 to approve audited FY26 results and consider a dividend, with a trading window closure in place until May 7.
Kriti Nutrients posted Q3 FY26 total income of ₹226.21 crore and PAT of ₹9.21 crore with EPS at ₹1.84; results were approved on February 5, 2026.
AGI Greenpac has started building a ₹1,000 crore aluminium beverage can plant in Hathras, targeting 1.6 billion cans annually at launch and operations in H1 2027.
DCW posted record Q4 FY26 sales of ₹609.06 crore and net profit of ₹18.08 crore as margins and interest coverage improved ahead of its May 6 earnings call.
Sun Pharma has signed a definitive agreement to buy US-listed Organon for $14 per share, valuing it at $11.75 billion enterprise value, subject to approvals.
Gallantt Ispat has recommended a 20% final dividend of ₹2 per share for FY26, alongside reporting Q4 and full-year revenue, profit and EPS, with key dates in May 2026.
Gallantt Ispat reported FY26 and Q4 earnings, proposed a ₹2 final dividend, announced independent director resignations effective May 5, and scheduled a revised earnings call for May 6.